Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,260 | -4,550 | -3,150 | -2,010 | -13,380 |
| Depreciation Amortization | 140 | 100 | 60 | 30 | 10,200 |
| Other Working Capital | -100 | -140 | -40 | 360 | -400 |
| Other Operating Activity | 1,830 | 230 | 60 | 20 | -1,160 |
| Operating Cash Flow | $-5,390 | $-4,360 | $-3,070 | $-1,600 | $-4,740 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -2 | -2 | 0 | -1 |
| Other Investing Activity | -678 | -428 | -258 | -130 | 241 |
| Investing Cash Flow | $-680 | $-430 | $-260 | $-130 | $240 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,660 | 1,630 | 140 | 0 | 12,140 |
| Financing Cash Flow | $1,660 | $1,630 | $140 | $0 | $12,140 |
| Beginning Cash Position | 8,020 | 8,020 | 8,020 | 8,020 | 380 |
| End Cash Position | 3,610 | 4,860 | 4,830 | 6,290 | 8,020 |
| Net Cash Flow | $-4,410 | $-3,160 | $-3,180 | $-1,730 | $7,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,390 | -4,360 | -3,070 | -1,600 | -4,740 |
| Free Cash Flow | -5,390 | -4,360 | -3,070 | -1,600 | -4,740 |